Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Admission to trading of AB Šiaulių bankas AT1 Notes on Global Exchange Market of Euronext Dublin
-
Caledonia approves quarterly dividend
-
Exor Press Release - Periodic Report on the Buyback Program
-
Caledonia Mining Corporation Plc: Results for the quarter and nine months ended September 30, 2024
-
Comment by the Management of AUGA group, AB on the Initiation of Restructuring
-
Notice on Convocation of the extraordinary General Meeting of Shareholders of AUGA group, AB on 4th December 2024
-
VAALCO Energy, Inc. Declares Fourth Quarter 2024 Dividend
-
Concentrix to share new insights on AI and intelligent experiences at Web Summit 2024
-
Caledonia Mining Corporation Plc: Encouraging results from exploration at the Motapa Gold Project
-
PERIODIC ANNOUNCEMENT ON THE ACQUISITION OF THE BANK'S OWN SHARES AND ITS RESULTS (WEEK 1)
-
AS Tallink Grupp: Managers’ Transactions
-
Egide: results of the capital increase
-
Intermediate Capital Group plc : Notification of Major Holdings
-
Transaction in own shares
-
Subsea7 share repurchases
-
Sampo plc’s share buybacks 8 November 2024
-
Novaturas earned EUR 61.1 mln. in the third quarter and recorded a profitable September
-
VentureX: Pioneering the Future of Cryptocurrency Investment with AI-Powered Blockchain Solutions
-
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
-
Start of Day Message
-
TGS Secures First 3D Streamer Contract for 2025 Summer Season
-
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
-
Arcadis reports transactions under its current share buyback program
-
AS Tallinna Sadam financial results for 2024 9 months and Q3
-
Issue of Additional Tier 1 Temporary Write-Down Notes
-
VEON Elevates its Youth Offering Through Banglalink’s AI-Powered Lifestyle App RYZE
-
UVKXE Strengthens Global Compliance Standards, Advancing a Safer Cryptocurrency Ecosystem
-
UVKXE Security System Upgraded to Provide Comprehensive Protection for User Assets
-
Pampered Bee Earns a 2024 Global Recognition Award for Excellence in Organic Baby Care
-
EBC Financial Group Registers Trademark in Chile, Strengthening Its Latin American Footprint
-
Compliance Exemplar: UVKXE Secures SEC License, Leading in Security and Trust
-
NOVONIX and Stellantis Sign Binding Offtake Agreement
-
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA⁽¹⁾ and Revises Upwards 2024 Financial Guidance Ranges
-
Sisecam's Nine-Month Net Sales Reach 136 Billion TL
-
Dubai’s First-Ever Crypto Content Creator Campus 2024 Kicks Off with Fresh Insights and Engaging Conversations
-
Tenaris to Commence a USD 700 million Share Buyback Program
-
Bark Unlocked the True Power and Designed a $BARK on the Solana Blockchain
-
MoroxHash: Two Years of Rigorous Testing Culminates in Public Launch
-
Ensurge Micropower ASA - Approval of share capital increase by conversion of convertible loan
-
NextEra Energy Investments and SOSA announce the 2025 Seed Competition, offering up to $1 million in funding
-
Bybit Web3 and Aptos Kick Off APT Ecosystem Airdrop
-
Muhammad Ali Center celebrates 11th annual Muhammad Ali Humanitarian Awards
-
Xinteria Surpasses $1 Billion in Trading Volume, Unveils Innovative Market-Making Technology
-
Monsha’at: Biban24 fuels regional SME growth and development with landmark agreements worth over SAR 35 billion launched during exhibition
-
FSIS Recall Release 030-2024 POSSIBLE LISTERIA CONTAMINATION
-
ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)
-
CV Pad Brings 0G AI Alignment Node Sale to Investors, Providing Early Access to Pioneering Decentralized AI Technology
-
Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer
-
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
-
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunothera


